IP Library › Granted Patent US 10,920,202
Granted Patent B1
US 10,920,202 · App. 16/998,705 · Granted Feb 16, 2021

Thermolabile Serratia Marcescens nuclease

Inventors: Zhenyu Zhu (Lynnfield, MA); Dapeng Sun (Lexington, MA); Michaela Shottes (Methuen, MA)
Assignee: AbClonal Science, Inc.
C12N9/16C12Y301/30002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,920,202
App. No.
16/998,705
Granted
Feb 16, 2021
Kind
B1
Abstract

Disclosed is an engineered thermolabile mutant of Serratia Marcescens Nuclease. In the same buffer as used for optimal enzyme activity, after 60° C. for 20 min, while the wild type retained 12.5% activity, the thermolabile mutant R146D/D156R/D229R/D245R (SEQ ID NO: 12, without the first 21 amino acids, which are a signal peptide) retained only 0.39% activity. Heat inactivation of the mutant, when it is used for protein purification, can be used after a period when substantial DNA in a protein has been degraded, but before unwanted degradation takes place.

Claims (7)

1. A thermolabile Serratia Marcescens Nuclease mutant, comprising: the amino acid sequence of SEQ ID NO: 12 not including the first 21 amino acids from the N-terminus.

2. A DNA sequence encoding the amino acid sequence of SEQ ID NO: 12 not including the first 21 amino acids from the N-terminus.

3. The DNA sequence of SEQ ID NO: 11.

4. A method of removing nucleic acids from a solution following protein production in said solution, comprising:

adding to the solution, after protein production, a thermolabile Serratia Marcescens Nuclease mutant having the amino acid sequence of SEQ ID NO: 12 not including the first 21 amino acids from the N-terminus, under conditions and times to permit the thermolabile Serratia Marcescens Nuclease mutant to degrade nucleic acid in the solution; and

terminating the Serratia Marcescens Nuclease mutant activity after a period sufficient to degrade nucleic acid in the solution, by heating the solution.

5. The method of claim 4 wherein said nucleic acid are DNA oligomers.

Cited By (4)
US 12,428,630 US 12,435,319 US 12,630,813 US 12,644,112